~~<i id='3C99BE8C9E'><strike id='3C99BE8C9E'><tt id='3C99BE8C9E'><pre id='3C99BE8C9E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

fashion

author：focus 2025-10-01 04:10:19 - browse：82

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

A couple billion here, a couple billion there, and pretty soon Eli Lilly hopes it will be talking about real money.

Eli Lilly agreed to purchase Point Biopharma Tuesday morning for $1.4 billion, a 90% premium, adding to its pipeline of cancer drugs. Point is developing cancer drugs that deliver a focused dose of radiation to tumor cells. Data for its lead medicine, for prostate cancer, are expected in the fourth quarter. It is also developing a drug for neuroendocrine tumors.

Point operates a 180,000-square-foot radiopharmaceutical manufacturing facility in Indianapolis, and a radiopharmaceutical research and development center in Toronto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Novo pauses ads for weight loss drug Wegovy amid demand

hotspot

Wikipedia

leisure time

entertainment

knowledge

explore

DarronCummings/APLONDON—AU.K.governmentagencyonTuesdaysaidthatitwon’trecommendEliLilly’sMounjaro—par

WSS

A new House health package & hospitals’ new site

Inside the rise of 'mukbang' eating videos

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

The 10 drugs up first for Medicare price negotiation

Why Novartis is changing the name of its research labs

How to fix cancer clinical trials' diversity problem

entertainment

fashion

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Hepatitis C has a cure — but many Americans still lack access to it

Novo: Oral version of Ozempic leads to 15% weight loss

What does generative AI mean for health care? We asked experts

Trump surgeon general acknowledges mistakes during Covid

Tori Bowie and the unacceptable rates of Black maternal death

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Affirmative action in medical school literally saved lives

AstraZeneca chief proposes a novel edit to the drug pricing bill

Wikipedia

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Illumina names Agilent executive as new CEO

Biogen nominates mother of director’s child to replace him on board

House transparency, PBM reform bill gains bipartisan support

'Make People Better': The CRISPR babies story you probably don't know

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

leisure time

entertainment

knowledge

explore